McKesson and Cardinal Health Extend CVS Drug Supply Deals Through 2032
BofA kept Buy ratings, calling the news a clearing event.
Already have an account? Sign in.
BofA kept Buy ratings, calling the news a clearing event.
Wave plans a single two-year trial for WVE-006 in AATD after FDA feedback, with a one-year review for possible accelerated approval.
A federal judge dismissed Chegg and Penske antitrust suits over Google AI Overviews, saying expected search traffic is not a contract.
Synopsys sees mid-teens revenue growth through 2030 and margins near 50%, while average analyst targets imply about 30% upside.